Muscle loss may predict lung surgery outcomes
NCT ID NCT05346185
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether having low muscle mass (sarcopenia) before lung cancer surgery affects how well patients recover. Researchers will follow 400 older adults having lung cancer surgery to see if sarcopenia is linked to survival and other outcomes. The goal is to find out if muscle loss can be used as a simple risk marker to guide care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors identify high-risk patients before lung cancer surgery, leading to better preparation and follow-up care.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove cause and effect, only that a link may exist. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul National University Hospital
Seoul, 03080, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Could muscle loss predict stroke recovery?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Can nerve changes explain Age-Related muscle loss?
- Your Tumor's DNA might predict immunotherapy success